We are currently in the process of updating our web site to reflect the announced plans to change our company name from Algernon Pharmaceuticals to Algernon Health. Please visit again soon as these changes continue to take effect across the entire web site.
Investor Relations
Christopher J. Moreau
Chief Executive Officer
T: 604-398-4175
chris@algernonpharmaceuticals.com
Transfer Agent
TSX Trust
733 Seymour Street
Suite 2310
Vancouver, BC V6B 0S6
Canada
T: 800-387-0825
shareholderinquiries@tmx.com
Auditor
Smythe LLP
Suki Gill
475 Howe Street
Suite 1700
Vancouver, BC V6C 2B3
Canada
T: 604-687-1231
sgill@smythe.com
Legal Counsel
McMillan LLP
Desmond Balakrishnan
1055 West Georgia Street
Suite 1500
Vancouver, BC V6E 4N7
Canada
T: 604-689-9111
Desmond.Balakrishnan@mcmillan.ca
